Tetsuro Komatsu

Tetsuro Komatsu

Auto-generated profile, based on publicly available information

Tetsuro Komatsu

Laboratory of Epigenetics and Metabolism, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2023 in The EMBO Journal
Verified
Journal Article
Open access
Uwe SchwartzUwe Schwartz
Uwe Schwartz
TKTetsuro Komatsu
Tetsuro Komatsu
CHClaudia Huber
Claudia Huber
FLFloriane Lagadec
Floriane Lagadec
CBConradin Baumgartl
Conradin Baumgartl
GLGernot Längst
Gernot Längst
Within the virion, adenovirus DNA associates with the virus-encoded, protamine-like structural protein pVII. Whether this association is organized, and how genome packaging changes during infection and subsequent transcriptional activation is currently unclear. Here, we combined RNA-seq, MNase-seq, ChIP-seq, and single genome imaging during early adenovirus infection to unveil the structure- and time-resolved dynamics of viral chromatin changes as well as their correlation with gene transcription. Our MNase mapping data indicates that the adenoviral genome is arranged in precisely positioned nucleoprotein particles with nucleosome-like characteristics, that we term adenosomes. We identified 238 adenosomes that are positioned by a DNA sequence code and protect about 60-70 bp of DNA. The incoming adenoviral genome is more accessible at early gene loci that undergo additional chromatin de-condensation upon infection. Histone H3.3 containing nucleosomes specifically replaces pVII at distinct genomic sites and at the transcription start sites of early genes. Acetylation of H3.3 is predominant at the transcription start sites and precedes transcriptional activation. Based on our results, we propose a central role for the viral pVII nucleoprotein architecture, which is required for the dynamic structural changes during early infection, including the regulation of nucleosome assembly prior to transcription initiation. Our study thus may aid the rational development of recombinant adenoviral vectors exhibiting sustained expression in gene therapy.

16 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
TKTetsuro Komatsu
Tetsuro Komatsu
TITakeshi Inagaki
Takeshi Inagaki
Histone lactylation H3K18la marks tissue-specific enhancers in combination with H3K27ac. It remains unclear whether and how these modifications differ. In this study, we dissected the specific roles of H3K18la- and H3K27ac-marked regions. We found that H3K18la predominantly localized at non-promoter regions with lineage-specific transcription factors and was strongly associated with enhancer activity and p300/CBP dependency. In contrast, H3K27ac was largely independent of these features; however, H3K27ac-occupied regions were selectively bound by the super-enhancer-enriched transcriptional coactivators BRD4 and MED1 and were responsible for gene expression involving liquid–liquid phase separation. The genomic regions covered by both H3K18la and H3K27ac best overlapped with super-enhancers. Thus, our study suggests that p300/CBP-dependent enhancer potential and BRD4/MED1-mediated enhancer cooperativity are separately encoded by H3K18la and H3K27ac, respectively, and exert synergistic enhancer activation when combined. Although the characteristics of H3K18la were similar to those of N-terminal acetylation of H2B (H2BNTac), a recently described enhancer signature, we found distinct genomic distributions of these marks. Collectively, our findings will advance the current understanding of how histone modifications establish enhancer landscapes.